Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Blood. 2004 Oct 1;104(7):1923-30. doi: 10.1182/blood-2004-03-0803. Epub 2004 Jun 10.

Abstract

Outcome of unrelated donor marrow transplantation is influenced by donor-recipient matching for HLA. Prior studies assessing the effects of mismatches at specific HLA loci have yielded conflicting results. The importance of high-resolution matching for all HLA loci has also not been established. We therefore examined the effects of HLA matching (low or high resolution or both) on engraftment, graft-versus-host disease (GVHD), and mortality in 1874 donor-recipient pairs retrospectively typed at high resolution for HLA-A, -B, -C, -DRB1, -DQ, and -DP. Mismatches at HLA-A, -B, -C, and -DRB1 each had similar adverse effects on mortality. Only HLA-A mismatches demonstrated significant adverse effects on GVHD. These adverse effects on outcome were more evident in transplants with low-resolution versus only high-resolution mismatches. Mismatches for HLA-DQ or -DP did not significantly affect outcome. When high-resolution mismatches at HLA-A, -B, -C, and -DRB1 were considered together, adverse effects on survival and GVHD were observed. We therefore conclude that matching for HLA-C should be incorporated into algorithms for unrelated donor selection. High-resolution mismatches at HLA-A, -B, -C, and -DRB1 adversely affect outcome, but less so than low-resolution mismatches. When clinical circumstances allow, high-resolution class I typing may help optimize donor selection and improve outcome.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Alleles
  • Bone Marrow Transplantation / methods*
  • Graft Survival
  • Graft vs Host Disease / etiology
  • HLA Antigens / chemistry*
  • HLA-A Antigens / chemistry
  • HLA-B Antigens / chemistry
  • HLA-C Antigens / chemistry*
  • HLA-C Antigens / immunology
  • HLA-DP Antigens / chemistry
  • HLA-DQ Antigens / chemistry
  • HLA-DR Antigens / chemistry
  • HLA-DRB1 Chains
  • Hematopoietic Stem Cells / immunology
  • Histocompatibility
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Testing*
  • Humans
  • Leukemia / therapy
  • Time Factors
  • Tissue Donors
  • Treatment Outcome

Substances

  • HLA Antigens
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-C Antigens
  • HLA-DP Antigens
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II